BiotechTube
Home/KalVista Pharmaceuticals/Michael D. Smith, PharmD
MD

Michael D. Smith, PharmD

Senior Vice President of Development

KalVista Pharmaceuticals

Roles

Senior Vice President of DevelopmentatKalVista Pharmaceuticals
Senior Vice President, Technical OperationsatOmeros Corporation

Therapeutic Areas

Rare DiseasesHereditary Angioedema (HAE)InflammationThrombosis

KalVista Pharmaceuticals Pipeline

DrugIndicationPhase
EKTERLY® (sebetralstat)Hereditary Angioedema (HAE) - On-demand treatmentApproved/Commercial
SebetralstatHAE - On-demand treatment in pediatric patients (2-11 years)Phase 3
Oral Factor XIIa InhibitorsHAE - Prophylactic treatmentPreclinical

Leadership Team at KalVista Pharmaceuticals

BL
Benjamin L. Palleiko
Chief Executive Officer and Director
BA
Bilal Arif
Chief Operating Officer
LA
Linea Aspesi
Chief People Officer
PK
Paul K. Audhya, MD, MBA
Chief Medical Officer
CH
Chris Hamblett, PhD
Senior Vice President of Corporate Development
BK
Brian Krex, JD
General Counsel
RM
Rachel M. Morten
Senior Vice President, Regulatory Affairs and QA
BP
Brian Piekos
Chief Financial Officer
NS
Nicole Sweeny
Chief Commercial Officer
CM
Christopher M. Yea, PhD
Chief Development Officer
View full KalVista Pharmaceuticals profile